Labcorp completes acquisition of Myriad Autoimmune’s Vectra testing business

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 13, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra ® rheumatoid arthritis (RA) assay.

Labcorp selects Medidata’s Sensor Cloud to expand decentralized clinical trial capabilities, enabling first-in-kind industry partnership for digital biomarker discovery

NEW YORK, N.Y., Sept. 13, 2021 - Medidata, a Dassault Systèmes company, and Labcorp Drug Development, a global company providing clinical laboratory and end-to-end drug development services, today announced they have entered into an agreement using the Medidata Sensor Cloud. Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio, enhancing their decentralized clinical trial (DCT) offerings.   

Labcorp to speak at Morgan Stanley 19th Annual Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 8, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of its executive management team will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, Sept. 13 at 3:30 p.m. ET.